Cours en clôture
Autres places de cotation
|
||
- USD | - |
Métier
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Innovative Drugs
100,0
%
| 243 | 100,0 % | 241 | 100,0 % | -1,03% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 243 | 100,0 % | 241 | 100,0 % | -1,03% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 54 | 01/12/07 | |
Director of Finance/CFO | 57 | 01/01/09 | |
Peter Carignan
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/22 |
Patrick O'brien
CMP | Compliance Officer | 60 | 01/12/14 |
Bruce Given
COO | Chief Operating Officer | 69 | 26/10/11 |
Vincent Anzalone
IRC | Investor Relations Contact | - | - |
Aaron Tan
AUD | Comptroller/Controller/Auditor | - | 01/07/21 |
Nadia Meshkova
TRE | Treasurer | - | - |
Tracie Oliver
PRN | Corporate Officer/Principal | 62 | 01/06/22 |
Matt Pulisic
PRN | Corporate Officer/Principal | - | 01/08/20 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Douglass Given
CHM | Chairman | 71 | 23/11/10 |
Michael Perry
BRD | Director/Board Member | 64 | 19/12/11 |
Adeoye Olukotun
BRD | Director/Board Member | 79 | 01/09/20 |
Hong Bo Lu
BRD | Director/Board Member | 53 | 01/04 |
Chief Executive Officer | 54 | 01/12/07 | |
William Waddill
BRD | Director/Board Member | 67 | 01/01/18 |
Mauro Ferrari
BRD | Director/Board Member | 64 | 19/08/10 |
Director/Board Member | 60 | 02/05/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 124 200 230 | 118 647 993 ( 95,53 %) | 0 | 95,53 % |
Coordonnées société
Arrowhead Pharmaceuticals, Inc.
177 East Colorado Boulevard Suite 700
91105, Pasadena
+626 304 3400
http://www.arrowheadpharma.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+20,17% | 127 Md | |
+24,67% | 117 Md | |
+25,44% | 27,67 Md | |
-17,74% | 20,33 Md | |
-15,17% | 16,79 Md | |
-15,21% | 15,63 Md | |
+11,91% | 14,84 Md | |
-47,10% | 14,65 Md | |
+54,50% | 14,43 Md |
- Bourse
- Actions
- Action ARWR
- Action
- Société ARRD RESE